Starpharma Holdings Limited SPHRY
2.97 USD -0.24 (-7.48%)
At closeNov 10, 2026, 4:00 PM EST
2.82 Day range 2.82
2.20 52-week range 5.98
- YTD
- +22.22%
- 1 year
- +29.13%
- Market cap
- 143.42M
- EPS (ttm)
- -0.13
- YTD return
- +22.22%
- 1-year return
- +29.13%
- Volume
- 1
- Avg volume
- 883
- Open
- 2.82
- Previous close
- 3.21
- Day's range
- 2.82 – 2.82
- 52-week range
- 2.20 – 5.98
5D -0.18 (-5.71%)
News
Starpharma (OTCMKTS:SPHRY) Stock Price Down 13.7% – Time to Sell? 
US Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma's phase 2 clinical-stage cancer treatments 
Stopping Infection: A Missing Link In The Delta Puzzle? Unloved Investment Opportunity In Starpharma 
Early-Stage Covid Treatment Prospects: Merck/Ridgeback Bio And Starpharma Lead The Pack 
Starpharma Up With News, Down With None; Timing Entry Makes Sense 
Starpharma signs DEP® ADC Research Agreement with MSD 
Starpharma Viraleze: COVID-19 Nasal Spray Development 
Stocks That Hit 52-Week Lows On Tuesday
Your note
Sign in to keep a note on SPHRY — it syncs with the Stock Master app.